Extraskeletal localization of 99mTc-labeled bone-seeking tracers in bone scintigraphy.
Arend SM, Pauwels EK, Arndt JW, Meinders AE.
Neth J Med. 1994 Oct;45(4):177-91.
PMID:7808581
Letter to the editor concerning "Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?".
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement.
Quartuccio N, Panareo S, Urso L, Sturiale L, Siracusa M, Arnone A, Alongi P, Baldari S, Bartolomei M, Arnone G.
Nucl Med Commun. 2021 Feb 1;42(2):198-204. doi: 10.1097/MNM.0000000000001321.
PMID:33252511
Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.
Bombardieri E, Setti L, Kirienko M, Antunovic L, Guglielmo P, Ciocia G.
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
Musumeci MB, Cappelli F, Russo D, Tini G, Canepa M, Milandri A, Bonfiglioli R, Di Bella G, My F, Luigetti M, Grandis M, Autore C, Perlini S, Perfetto F, Rapezzi C.